Why is Winner Medical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -3.71% and Operating profit at -24.55% over the last 5 years
2
Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at CNY 1,867.4 MM
- RAW MATERIAL COST(Y) Fallen by -11.49% (YoY)
- DEBTORS TURNOVER RATIO(HY) Highest at 7.86 times
3
With ROE of 7.77%, it has a fair valuation with a 1.37 Price to Book Value
- Over the past year, while the stock has generated a return of -32.06%, its profits have risen by 3.8%
- At the current price, the company has a high dividend yield of 0.9
4
Below par performance in long term as well as near term
- Along with generating -32.06% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Winner Medical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Winner Medical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Winner Medical Co., Ltd.
-32.06%
-0.13
24.39%
China Shanghai Composite
21.43%
1.55
13.83%
Quality key factors
Factor
Value
Sales Growth (5y)
-3.71%
EBIT Growth (5y)
-24.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.67
Tax Ratio
20.25%
Dividend Payout Ratio
56.82%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.99%
ROE (avg)
14.21%
Valuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.37
EV to EBIT
12.73
EV to EBITDA
8.81
EV to Capital Employed
1.41
EV to Sales
1.36
PEG Ratio
NA
Dividend Yield
0.87%
ROCE (Latest)
11.05%
ROE (Latest)
7.77%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,867.4 MM
RAW MATERIAL COST(Y)
Fallen by -11.49% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 7.86 times
PRE-TAX PROFIT(Q)
Highest at CNY 341.74 MM
EPS(Q)
Highest at CNY 0.43
-4What is not working for the Company
INTEREST(Q)
At CNY 12.51 MM has Grown at 1,593.44%
OPERATING PROFIT(Q)
Lowest at CNY 353.16 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 13.18 %
Here's what is working for Winner Medical Co., Ltd.
Operating Cash Flow
Highest at CNY 1,867.4 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
Highest at CNY 341.74 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
EPS
Highest at CNY 0.43
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Debtors Turnover Ratio
Highest at 7.86 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -11.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Winner Medical Co., Ltd.
Interest
At CNY 12.51 MM has Grown at 1,593.44%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit
Lowest at CNY 353.16 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 13.18 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales






